Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.310
-0.230 (-6.50%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Lantern Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
3634476689120
Upgrade
Market Cap Growth
-26.05%-26.05%-29.06%-26.55%-25.41%-
Upgrade
Enterprise Value
127281699
Upgrade
Last Close Price
3.543.194.286.047.9819.25
Upgrade
PB Ratio
1.801.621.141.171.256.08
Upgrade
P/TBV Ratio
1.621.621.141.171.256.08
Upgrade
Debt / Equity Ratio
0.010.010.010.000.000.01
Upgrade
Quick Ratio
5.545.5415.7419.9430.4834.81
Upgrade
Current Ratio
5.835.8316.1820.9931.2636.64
Upgrade
Return on Equity (ROE)
-66.93%-66.93%-32.93%-22.35%-27.09%-57.24%
Upgrade
Return on Assets (ROA)
-40.12%-40.12%-21.80%-13.59%-15.36%-33.89%
Upgrade
Return on Capital (ROIC)
-44.38%-44.38%-22.98%-14.11%-15.82%-35.59%
Upgrade
Earnings Yield
-58.21%-60.41%-34.31%-21.75%-13.85%-4.94%
Upgrade
FCF Yield
-49.94%-51.81%-30.88%-19.51%-11.88%-4.74%
Upgrade
Buyback Yield / Dilution
0.74%0.74%0.08%0.50%-153.31%-117.61%
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q